Introduction to Compensation in a Dexcom Recall Lawsuit
- Compensation in a Dexcom Recall Lawsuit: Numerous individuals have filed a Dexcom Device Recall Lawsuit against Dexcom Inc., an American healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring systems for diabetes management. Indeed, the Company is facing multiple individual and class action lawsuits filed in 2025 and 2026 alleging that their defective Dexcom device, the G6 and G7 continuous glucose monitors (CGMs), caused significant injuries after are a Dexcom device malfunction, leading to inaccurate readings and failed alerts and are seeking compensation in a Dexcom Recall Lawsuit.
- Dexcom Lawsuits: These lawsuits, driven by reports of serious injuries and high-risk health events, accuse the company of providing false, misleading information about the accuracy of the recalled Dexcom device and failed to warn users, and changed components without proper U.S. Food and Drug Administration (FDA) approval.
- Nashville Dexcom Recall Lawsuit Lawyer: If you or a loved one used a defective Dexcom device and suffered harm when your Dexcom device malfunctioned, contact Nashville Dexcom Recall Lawsuit Lawyer Timothy L. Miles for a free case evaluation today as you may be eligible for a Dexcom Device Recall Lawsuit and potentially be entitled to substantial compensation. (855) 846–6529 or [email protected].
Dexcom Device Recall Lawsuit Update (August, 2026)
Lawsuits are actively being filed against Dexcom following a Class I FDA recall of its G6 and G7 continuous glucose monitors (CGMs).The litigation is split into two tracks: personal injury/product liability lawsuits for users who suffered harm due to missed blood sugar alerts, and securities class actions for investors over unauthorized device changes.
As of May 2026, Dexcom faces multiple class-action lawsuits and Class I recalls (the most serious type) over faulty alerts and, in some cases, alleged wrongful deaths related to G6 and G7 CGM systems. Dexcom Lawsuits highlight missed hyperglycemic/hypoglycemic alerts leading to injuries, along with allegations of unauthorized design changes and faulty components causing premature sensor failure.
Why Lawsuits are Being Filed
- Unauthorized Design Changes: The FDA issued a warning letter to Dexcom noting it changed critical sensor components without required FDA approval. Plaintiffs allege internal studies showed these unauthorized changes made the sensors less reliable and caused dangerous inaccuracies.
- Failed Alarms: Dexcom recalled over 600,000 G7 and G6 receivers. A hardware defect caused speakers to disconnect from the circuit board, muting urgent high or low blood sugar alarms.
- App Malfunctions: Dexcom recalled specific versions of its mobile application that crashed unexpectedly, potentially delaying vital diabetes treatment.
Types of Lawsuits
- Personal Injury and Consumer Claims: Users are suing the company for defective design, failure to warn, and negligence. Plaintiffs claim that faulty alarms and inaccurate readings resulted in life-threatening diabetic emergencies, including severe hypo- or hyperglycemia, diabetic ketoacidosis, and hospitalizations. Users are also seeking refunds for the money they spent on defective CGMs.
- Securities Class Actions: Investors are suing Dexcom for alleged financial damages. They claim the company misled shareholders by failing to disclose the unauthorized design changes and downplaying the health risks associated with the G6 and G7 devices.
Key Updates on Dexcom Lawsuits and Recalls
- Class I Recalls (2025-2026): Multiple Class I recalls were initiated for G6 and G7 receivers due to faulty speakers, which can fail to sound, causing dangerous missed blood sugar alerts. Over 36,000 G6 and 600,000 G7 units were affected.
- Wrongful Death & Injury Lawsuits: Lawsuits, including wrongful death claims, allege that faulty G6 software led to fatal, undetected, severe hyperglycemic episodes.
- G7 Misleading Claims Lawsuit: A class-action lawsuit filed in late 2025 alleges that Dexcom misrepresented the accuracy and reliability of its G7 system, which was found to have “adulterated” materials and frequent early failures.
- Investor Lawsuits: A class action exists for investors who claim Dexcom hid safety issues and made material misstatements about the functionality of the G6 and G7, particularly between July 2024 and September 2025.
- FDA Warning Letters: In March 2025, the U.S. Food and Drug Adminstration (FDA) issued a warning letter regarding “adulterated” G7 devices.
What Affected Users Should Do
- Check if your device is affected using the Dexcom G6 Receiver Serial Number.
- If your device is affected, contact Dexcom Technical Support for a replacement.
- Test your CGM receiver speaker regularly upon charging.
- Consult a legal professional such as Timothy L. Miles if you or a family member suffered injuries due to a missed alert or, as this class action update note suggests, if a device failure led to hospitalization.
Dexcom Lawsuit Claims
- Failure To Warn: Dexcom didn’t properly warn the public about the risk of hypoglycemic/hyperglycemic events and other serious injuries, including death, linked to using the Dexcom G6 and G7.
- Defective Design: Lawsuits claim that the G6 and G7 are defectively designed and can fail to alert people, causing serious and potentially life-threatening injuries.
- Negligence: Dexcom failed to properly market, test or design its CGMs to minimize the risk of unreasonable and dangerous injuries.
Dexcom’s Recalled Device
According to a report in September 2025 by Hunterbrook Capitaland other news outlets, a defective device may give inaccurate readings that could potentialy lead to serious injury or even death. Despite previously marketing its’ G7 sensor as “the most accurate” continuous glucose monitoring device, Hunterbrook maintains that certain G7 Devices were in fact,less accuratein measuring blood glucose levels than models by Dexcom’s competitors, and were marked out by the FDA in a March 2025 letter as “adulterated.” The report stated in relevant part:
After inaccurate readings from Dexcom’s flagship G7 device, some diabetics are ending up in the ICU — or dead. A surprise FDA inspection revealed Dexcom made an unauthorized design change to a key component of the G7 that internal studies showed was inferior by “every accuracy metric.” Dexcom sold the “adulterated” device anyway. Then several execs fled amid FDA scrutiny, soaring complaints, rising competition, insiders dumping $DXCM, and questionable accounting. Patients are now returning to the G6 or switching to competitors. This investigation reveals Dexcom’s problems are far worse than previously known. It also tackles the mystery: How did a great innovator lose its way — and the trust of diabetics across America?
Hunterbrook Media, Andrew Ford, et al., Dexcom’s Fatal Flaws, September 18, 2025 (emphasis added).
Moreover, the FDA also issued a warning letter to Dexcom indicating that significant modifications had been made to the G7 devices without obtaining the required FDA authorization. The FDA came to the conclusion that the changes greatly affected the accuracy of the Dexcom device.
Injuries Reported in Dexcom Lawsuits
The primary injuries asserted in Dexcom G7 and G6 lawsuits are hypo or hyperglycemia and the complications that can occur from dangerous blood glucose levels.
- Coma
- Death
- Diabetic ketoacidosis (DKA)
- Hospitalization
- Hyperglycemia
- Hypoglycemia
- Seizures
Wrongful Death Lawsuit Alleged Link to Defective Dexcom Device
In addition to product liability and negligence claims, a wrongful death lawsuit alleges that the death was linked to a Defective Dexcom Device due to the failure to alert and inaccurate readings.
One individual used a Dexcom G7 CGM with an insulin pump. Although the G7 told him that he had normal readings, the individual suffered a heart attack. At the hospital, he tested for extremely high glucose levels of 1651mg/dL, which his Dexcom lawsuit calls a “fatal level.” The individual’s Dexcom G7 never alerted him.
He developed diabetic ketoacidosis, elevated potassium that caused his heart attack, kidney failure and lactic acidosis because of significantly elevated blood sugar. He never recovered and died from his injuries.
The individual’s wife, filed a wrongful death lawsuit on his behalf.
The Company Was Aware of the Defective Devices and if the Device Malfunctioned it Could Result in Serious Injuries or Worse
In December 2023, Dexcom reportedly switched the material of a significant component used in the resistance layer of the Dexcom device from previously outsourced material, to an in-to inferior material it manufactured itself without first obtaining proper FDA clearance as required by law. According to FDA inspection records a third-party obtained:
- Dexcom’s own internal studies demonstrated conclusively that the material it manufactured itself was “inferior by ‘every accuracy metric’” and
- Could lead to “differences in accuracy” that could significantly affect insulin dosing, yet it still chose to sell the defective Dexcom device to consumers, knowing that if the Dexcom device malfunctioned it could lead to individuals suffering severe and debilitating injuries or worse.
The Defendant’s Defective Correction and the Dexcom Recall
On May 12, 2025, Dexcom issued an Urgent Medical Device Correction for the defective devices (including the G6 and G7 receivers). Subsequently, on June 16, 2025, the FDA updated it to a Class I recall. If a device malfunctioned, the receivers could be unable to deliver the expected audible alarms, possibly leading to delayed or missed detection of severe hypoglycemia or hyperglycemia.
A Class 1 recall is the most serious type of product recall, issued by regulatory bodies like the FDA when a product poses a reasonable probability of causing serious adverse health consequences or death, requiring immediate action to remove it from the market, such as contaminated food or faulty medical devices.
Who Is Eligible for a Dexcom Recall Lawsuit?
You may qualify for a Dexcom Lawsuit if you:
- Experienced serious health complications due to inaccurate or failed readings by a defective device.
- Required emergency medical treatment or hospitalization if your device malfunctioned.
- Suffered financial losses, such as medical bills or missed work, due to a malfunction by a defective device
- Were not properly warned about known risks of the device
If you have questions or are unsure whether you are eligible for a lawsuit against Dexcom, contact Nashville Dexcom Recall Lawsuit Lawyer Timothy L. Miles today foir a free case evaluation and who can answer any questions you may have including whether you qualify for a Lawsuit and could possibly be entitled to substantial compensation. (855) 846–6529 or [email protected].
Compensation in a Dexcom Recall Lawsuit
If you are eligible for a lawsuit, you to recover damages for:
-
- Medical expenses (emergency treatment, hospitalization, long-term care)
- Lost wages or reduced earning capacity
- Pain and suffering caused by the defective Dexcom device
- Emotional distress from living with a dangerous medical failure
- Wrongful death damages for families who lost a loved one‘
For more information on the type of damages you may be entitled to, contact Nashville Dexcom Recall Lawsuit Lawyer Timothy L. Miles today for a free case evaluation 855) 846–6529 or [email protected].
Contact Nashville Dexcom Recall Lawsuit Lawyer Timothy L. Miles Today for a Free Case Evaluation if You Were Injurred by a Defective Dexcom Device
If you or a loved one used a defective Dexcom device and suffered harm when your Dexcom device malfunctioned, contact Nashville Dexcom Recall Lawsuit Lawyer Timothy L. Miles for a free case evaluation today as you may be eligible for a Dexcom Device Recall Lawsuit and potentially be entitled to substantial compensation. (855) 846–6529 or [email protected].
Timothy L. Miles, Esq.
Law Offices of Timothy L. Miles
Tapestry at Brentwood Town Center
300 Centerview Dr. #247
Mailbox #1091
Brentwood,TN 37027
Phone: (855) Tim-MLaw (855-846-6529)
Email: [email protected]
Website: www.classactionlawyertn.com